Featured partnerSign up to Lightyear and get up to €100 in a free fractional shareCapital at risk, terms apply. Seek guidance if necessary. Claim Up to €100 Capital at risk, terms apply. Seek guidance if necessary. - OpenAI was still a private company on 8 October 2026, so no European broker could sell you a genuine OpenAI share.
- OpenAI submitted a confidential draft IPO filing on 8 June 2026 and said it had not decided on timing.
- Robinhood Europe’s OPAI is a contract with Robinhood that tracks a price, so it carries no OpenAI shares and no shareholder rights.
- We think most European investors should wait for an official listing with audited accounts and a verified ticker.
Can you buy OpenAI stock today?
No. OpenAI shares did not trade on any exchange on 8 October 2026, so a normal broker order has nothing to fill.
Every listed company has a ticker symbol, an exchange, a published prospectus, and an offer price. OpenAI had announced none of these by that date, nor any allocation for European retail investors.
The company’s legal name causes confusion. Its business entity is OpenAI Group PBC, and PBC stands for public benefit corporation, a US company form that asks directors to weigh a stated public purpose alongside profit. The label says nothing about exchange trading, and such a company can stay private indefinitely. OpenAI’s structure page explains that the non-profit OpenAI Foundation controls the business through special voting rights.
Our guide to Anthropic stock for European investors works through an almost identical case for another large private company.
The filingWhere OpenAI is in the IPO process
An S-1 is the registration document a company files with the US Securities and Exchange Commission before it sells shares to the public. OpenAI announced on 8 June 2026 that it had submitted a draft version confidentially.
Five stages sit between a private company and a share you can buy. OpenAI has cleared one of them.
- Private company Completed
Shares are held privately and do not trade on an exchange.
- Confidential S-1 submitted Current stage
Submitted 8 June 2026. SEC staff review the draft while it stays private.
- Public S-1 Not reached
The first document outsiders can read, with audited accounts and share-class rights.
- IPO price and allocations Not reached
An offer price is set and shares are allocated to investors.
- Exchange trading Not reached
A ticker exists and a normal broker order can be filled.
Confidential means the document stays private while SEC staff review it and the company revises it, a process the SEC guidance on draft registration statements sets out. A company can begin that review without committing to a timetable, and it can revise, delay, or abandon the plan.
OpenAI said it had not decided on timing and might remain private for a while, and the announcement did not constitute an offer to sell securities. The submission gives OpenAI the option to go public. It fixes no date and commits the company to no IPO.
The version that matters to you has not appeared. A public S-1 would show audited accounts, the risks the company names itself, the rights attached to each share class, and an indicative price range. Until it exists, nobody outside OpenAI can value the business on public information, and we will not guess at a listing date.
Available routesWhat can European investors buy today?
Several products reference OpenAI. None is an OpenAI share, and the difference sits in what you legally own.
Four routes are discussed as OpenAI exposure. Only one of them is an OpenAI share, and it is not available.
- What it is
- Direct equity in OpenAI Group PBC
- What you own
- Ownership and shareholder rights after a listing
- Available today
- No
- What it is
- Derivative contract with Robinhood
- What you own
- A claim against Robinhood, no OpenAI shares and no shareholder rights
- Available today
- In eligible countries
- What it is
- Private-market vehicle or future delivery agreement
- What you own
- An interest that is void without OpenAI’s written consent, illiquid and generally unsuitable for beginners
- Available today
- Only with valid documents and consent
- What it is
- Listed indirect exposure
- What you own
- Shares in the fund or the listed company rather than OpenAI
- Available today
- Yes
Robinhood Europe sells a product called OPAI. Its own Stock Token disclosure describes Classic Stock Tokens as derivative contracts between the customer and Robinhood, priced by reference to underlying securities without granting rights to those securities. A derivative is an agreement whose value follows the price of something else without giving you the thing itself. Robinhood warns that investors may lose the full amount invested through market conditions or the firm’s insolvency.
A live product price does not create a public OpenAI share price. That number reflects one company’s product terms. Our Robinhood Europe review covers the platform, and our Kraken xStocks guide explains how tokenised stock products work.
Robinhood Ventures Fund I trades on the New York Stock Exchange as RVI. Robinhood announced on 22 April 2026 that the fund had bought approximately 75 million US dollars of OpenAI common stock on 17 April 2026. An RVI investor owns shares in the fund, which holds many private companies, rather than shares in OpenAI.
Microsoft holds the largest known historical interest in OpenAI among listed companies. At the close of the 2025 recapitalisation, OpenAI reported the Foundation at 26%, Microsoft at roughly 27%, and employees and other investors at 47%. Those figures predate the 2026 funding round, so treat them as history. Microsoft shares represent the whole of Microsoft, and an AI-themed ETF holds a basket of listed companies. Our ETF investing guide explains how to check a fund’s holdings file.
Private marketsPrivate offers and the consent rule
OpenAI has published a rule that settles most questions about private offers, and we treat it as the first test for anything you are shown.
OpenAI’s policy on unauthorised equity transactions states that all of its equity carries transfer restrictions and that any transfer, direct or indirect, requires the seller to obtain OpenAI’s written consent. A transfer made without that consent is void. The policy names equity sales, SPVs, tokenised interests, and forward contracts. An SPV is a fund created to hold a single asset so that several investors can share it, and a forward is an agreement to deliver something at a future date.
OpenAI also says that not every offer of exposure is necessarily problematic, though it warns that unauthorised transactions may carry no economic value. The difference shows up in the paperwork rather than in the pitch.
Before considering any private offer, require the legal issuer’s registered name, the exact instrument, evidence of OpenAI’s written consent, every fee, and the exit terms.
Four things justify walking away: an unsolicited approach, deadline pressure, a request to pay cryptocurrency into a personal wallet, and a promised guaranteed IPO allocation. We are not lawyers, and a qualified adviser should read the documents before you sign.
After a listingWhat to check if OpenAI lists
If a genuine listing arrives, the checks are ordinary ones.
- Confirm the official ticker and exchange in the exchange’s own listings, then read the published prospectus.
- Check the exact product your broker offers, since an ordinary share, a depositary receipt, a CFD, and a token differ in rights, cost, and tax.
- Confirm that your country and account type qualify.
- Compare commission, custody charges, spread, and currency conversion. A euro account buying a dollar share pays a conversion cost each way, so a 0.5% rate costs 10 euros on a 2,000 euro purchase.
- Use a limit order, which caps the price you pay, rather than a market order.
- Keep the position small enough that one company cannot damage your portfolio.
Our best stock brokers in Europe guide and our Interactive Brokers review cover accounts and costs. Neither confirms that any broker will offer OpenAI, and none can before a ticker exists.
Our assessmentOur view
Wait for the official listing. That is our position for most European retail investors. A listing turns an unverifiable opportunity into a documented security with audited accounts, defined rights, and a regulated exchange behind it. Waiting might cost you an early price move. Acting through an unverified product can cost you the money and any means of recovering it.
An experienced investor with professional status, legal advice, evidence of OpenAI’s written consent, and money they can lock away indefinitely might reasonably examine a private vehicle. A gap in any one of those conditions is a reason to stop.
We recommend no substitute, including OPAI, RVI, Microsoft, and AI funds. Holding none of them until OpenAI publishes real terms remains a sensible decision.
FAQFrequently asked questions
No. OpenAI had no listed share on 8 October 2026, so a broker order has nothing to fill. Anything marketed as OpenAI exposure is a different product with different rights.
OpenAI had announced no ticker, exchange, public offer price, or European retail allocation by 8 October 2026. Treat any symbol circulating before an official company announcement as unverified.
No. Robinhood describes its Stock Tokens as derivative contracts between you and Robinhood that reflect a price without granting rights to the underlying securities, and it warns that investors may lose the full amount invested.
No. Microsoft shares represent the whole of Microsoft’s business, and an AI ETF holds a basket of listed companies. Both give broad AI exposure and can move independently of OpenAI’s value.
Only after checks. OpenAI says a transfer made without its written consent is void, so ask for proof of that consent, the issuer’s registered name, your exact rights, every fee, and the exit terms. Treat an unsolicited offer or deadline pressure as a reason to walk away.
Featured partner: Capital at risk. Provider of the investment services is Lightyear Europe AS for the EU. Terms apply: lightyear.com/terms. Seek qualified advice if necessary. This is not investment advice.
